AU2012301656A1 - Pharmaceutical product and method of analysing light exposure of a pharmaceutical product - Google Patents

Pharmaceutical product and method of analysing light exposure of a pharmaceutical product Download PDF

Info

Publication number
AU2012301656A1
AU2012301656A1 AU2012301656A AU2012301656A AU2012301656A1 AU 2012301656 A1 AU2012301656 A1 AU 2012301656A1 AU 2012301656 A AU2012301656 A AU 2012301656A AU 2012301656 A AU2012301656 A AU 2012301656A AU 2012301656 A1 AU2012301656 A1 AU 2012301656A1
Authority
AU
Australia
Prior art keywords
photosensitive
active ingredient
property change
change
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012301656A
Other languages
English (en)
Inventor
Jeremy GUO
Deborah Shnek
Paula SPENCER
Li Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU2012301656A1 publication Critical patent/AU2012301656A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • B65D79/02—Arrangements or devices for indicating incorrect storage or transport
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change

Landscapes

  • Mechanical Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Packages (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2012301656A 2011-09-02 2012-08-31 Pharmaceutical product and method of analysing light exposure of a pharmaceutical product Abandoned AU2012301656A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161530824P 2011-09-02 2011-09-02
US61/530,824 2011-09-02
PCT/US2012/053450 WO2013033600A1 (en) 2011-09-02 2012-08-31 Pharmaceutical product and method of analysing light exposure of a pharmaceutical product

Publications (1)

Publication Number Publication Date
AU2012301656A1 true AU2012301656A1 (en) 2014-01-16

Family

ID=46982918

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012301656A Abandoned AU2012301656A1 (en) 2011-09-02 2012-08-31 Pharmaceutical product and method of analysing light exposure of a pharmaceutical product

Country Status (13)

Country Link
US (1) US20140315187A1 (zh)
EP (1) EP2750989A1 (zh)
JP (1) JP2014529473A (zh)
KR (1) KR20140058669A (zh)
CN (1) CN103917458A (zh)
AU (1) AU2012301656A1 (zh)
BR (1) BR112014004591A2 (zh)
CA (1) CA2840637A1 (zh)
CL (1) CL2014000104A1 (zh)
EA (1) EA201490555A1 (zh)
MX (1) MX2014002533A (zh)
WO (1) WO2013033600A1 (zh)
ZA (1) ZA201309704B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202785A1 (en) 2015-06-17 2016-12-22 Novozymes A/S Container
IL250601B (en) * 2017-02-14 2018-05-31 Marpaz Tech Ltd Container for light sensitive material
WO2020172257A1 (en) * 2019-02-22 2020-08-27 The Chemours Company Fc, Llc Methods for determining photosensitive properties of a material

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3483106D1 (de) * 1983-02-25 1990-10-11 Lifelines Technology Inc Ueberwachungsverfahren fuer incrementale umgebungseinwirkungen auf produkte, erfassbar fuer fortschreitende qualitaetsaenderungen.
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP1132471A3 (de) 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5962406A (en) 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
JPH06174600A (ja) * 1992-09-16 1994-06-24 Caterpillar Inc 状態変化を表示する方法および装置
PT672141E (pt) 1992-10-23 2003-09-30 Immunex Corp Metodos de preparacao de proteinas oligomericas soluveis
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
JP4435304B2 (ja) 1995-06-29 2010-03-17 イミュネックス・コーポレーション アポトーシスを誘導するサイトカイン
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001036637A1 (en) 1999-11-17 2001-05-25 Immunex Corporation Receptor activator of nf-kappa b
WO2001083525A2 (en) 2000-05-03 2001-11-08 Amgen Inc. Modified peptides, comprising an fc domain, as therapeutic agents

Also Published As

Publication number Publication date
CA2840637A1 (en) 2013-03-07
ZA201309704B (en) 2014-08-27
BR112014004591A2 (pt) 2017-03-28
EA201490555A1 (ru) 2014-07-30
US20140315187A1 (en) 2014-10-23
MX2014002533A (es) 2014-08-26
KR20140058669A (ko) 2014-05-14
CN103917458A (zh) 2014-07-09
EP2750989A1 (en) 2014-07-09
JP2014529473A (ja) 2014-11-13
CL2014000104A1 (es) 2014-07-25
WO2013033600A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
Le Basle et al. Physicochemical stability of monoclonal antibodies: a review
Lubiniecki et al. Comparability assessments of process and product changes made during development of two different monoclonal antibodies
AU2013212587B2 (en) Stabilized formulations containing anti-Ang2 antibodies
Visser et al. Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab
Razinkov et al. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools
Kim et al. Aggregation of anti-streptavidin immunoglobulin gamma‐1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration
CN101889209A (zh) 评价在含有机基聚硅氧烷的悬浮液中蛋白质聚集的方法和用含蛋白质溶液的有机基聚硅氧烷涂布的医疗制品
US20140315187A1 (en) Pharmaceutical Product and Method of Analysing Light Exposure of a Pharmaceutical Product
Shi et al. Recognition of human IgG1 by Fcγ receptors: structural insights from hydrogen–deuterium exchange and fast photochemical oxidation of proteins coupled with mass spectrometry
ES2905615T3 (es) Sistemas y métodos para evaluar moduladores de puntos de control inmunitario
US20170210821A1 (en) Antibodies that Recognize Red Blood Cell Antigens
WO2013181486A1 (en) Stabilized formulations containing anti-dll4 antibodies
US20240124549A1 (en) Immunoassays and engineered proteins for monitoring antibody treatments to the immune checkpoint inhibitors pd1 and pd-l1
Kagdi et al. Determination of holdup volume and transient contact compatibility of closed system transfer devices for a reconstituted lyophilized drug product
Schreiber et al. Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
Gürel et al. Optimized methods for analytical and functional comparison of biosimilar mAb drugs: A case study for Avastin, Mvasi, and Zirabev
US20210318333A1 (en) Methods of glycoprotein analysis
Ostrov et al. The interference of monoclonal antibodies with laboratory diagnosis: clinical and diagnostic implications
Gurel et al. Structural and functional analysis of CEX fractions collected from a novel avastin® biosimilar candidate and its innovator: a comparative study
AU2021209866B2 (en) Deglycosylation methods for electrophoresis of glycosylated proteins
CA2999866C (en) Composition and methods for assessing sensitivity and specificity of antibody detection reagents
Mazzeo et al. Stability studies for biologics
Razinkov et al. High-throughput formulation development of biopharmaceuticals: practical guide to methods and applications
CN102532298A (zh) 与自身抗体特异性结合的abcc3抗原多肽及应用
US20180031569A1 (en) Devices for detection of antibodies against therapeutic drugs

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period